AGC Biologics
Share
AGC Biologics has successfully manufactured more than 200 biological projects, from pre-clinical studies through commercial approvals.
We offer multiple cGMP manufacturing lines at a variety of scales for mammalian cell culture and microbial fermentation
AGC Biologics is proud to partner with Flen Health to manufacture two recombinant enzymes for a next-generation wound care therapy targeting diabetic foot ulcers. ๐งฌ
Our Heidelberg site will lead process development, scale-up, and GMP microbial manufacturing, building on a successful 2025 feasibility program, in support of Flen Health's upcoming IND submission and Phase II clinical trials.
Read the full announcement: https://hubs.ly/Q04y4WFD0
09/23/2026
โฐ One week to go! Join us Wednesday, September 30 at 11:00 AM ET, for Outsourced Pharma's ๐๐๐ฉ๐๐๐ข๐ฅ๐ข๐ญ๐ข๐๐ฌ ๐๐ฉ๐๐๐ญ๐: ๐ฆ๐๐๐ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ & ๐๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐ข๐ง๐ .
Hear from Dominik Layer, Process Development Team Lead at AGC Biologics, as he discusses how to navigate manufacturing complexity, raw materials sourcing, formulation, and end-to-end logistics and production strategies to bring high-quality mRNA therapeutics into the clinic, and beyond.
๐ Register here: https://hubs.ly/Q04y4JSG0
09/22/2026
๐ Looking for a CDMO partner in the APAC region for your biologics development and manufacturing projects?
Meet with our team at BioJapan 2026, October 7-9 in Yokohama, Japan! Stop by ๐๐จ๐จ๐ญ๐ก #๐-๐๐ or request a meeting during the event: โก๏ธ https://hubs.ly/Q04xSb-60
This year is special to us, as we have launched our new site in Yokohama โ boasting 5,000 L capacity for mammalian production, cell therapy manufacturing, and LNP-based mRNA production.
Bring your questions and let our experts help find solutions that move your project to the next stage!
09/21/2026
Join us, October 6-8, for CPHI Milan 2026!
Our schedule is filling fast.. reach out to us to arrange a discussion about your biologics or cell and gene programs: https://hubs.ly/Q04xQ55r0
You can also find us in ๐๐จ๐จ๐ญ๐ก #๐๐๐๐ for an impromptu discussion.
We look forward to seeing you in Milan!
Good manufacturing practices (GMP) help ensure safe therapies reach the patients who need them.๐จโ๐ฌ
Thatโs why we are committed to meeting the regulatory standards that guide development and manufacturing of high-quality biologics, cell and gene therapies, and mRNA-based therapeutics.๐งฌ
At AGC, our work is about more than manufacturing a product that meets specifications. Itโs about delivering a safe therapeutic with the potential to improve patient outcomes.
Join us in recognizing World Patient Safety Day 2026!
๐ฌ In this video, Tony Tavares, Principal Scientist in Downstream Process Development, explains how our team generates highly-pure bispecifics, trispecifics, ADCs, mRNAs, monoclonal antibodies, and more at our Seattle facility.
Learn how we utilize process analytical technologies and the latest purification methods to deliver products meeting strict specifications at any scale.โญ๏ธ
09/15/2026
Struggling to produce stable complex proteins like bispecifics, trispecifics, and atypicals?
Our whitepaper provides insights into how we leverage transposase technology to engineer cell lines that produce complex proteins with greater stability, consistency, and yields. ๐ช
Learn how a semi-targeted integration strategy can deliver a 10-fold increase of your complex protein โฌ๏ธ
https://hubs.ly/Q04xgDXJ0
Are your production and regulatory strategies robust enough to keep pace with the rapidly changing mRNA therapeutic sector? ๐ค
Join AGC expert Dominik Layer, Process Development Team Lead, on September 30, at 11:00 AM ET for an Outsourced Pharma Capabilities Update on mRNA Development & Manufacturing. Learn how to navigate manufacturing complexity, raw materials sourcing, formulation, and end-to-end logistics challenges to bring high-quality therapeutics to market.
๐Register here: https://hubs.ly/Q04xgwDl0
09/10/2026
Produce viral vectors that meet regulatory expectations with AGC Biologicsโ validated manufacturing platforms, ProntoLVVโข and BravoAAVโข.๐ซ
โก๏ธRead our case study and learn how our plug-and-play, scalable approach to vector manufacturing increases CMC preparedness and produces safe, robust materials for clinical application.
https://hubs.ly/Q04wL3BZ0
09/08/2026
Inclusion bodies: refolding success starts upstream!
๐ AGC Biologics experts, Jรถrg Ohl, Associate Vice President, Business Development, Microbial, and Robert Lindner, Head of Downstream Process Development, in partnership with BioSpaceยฎ, have published a white paper that explains how ๐ณ๐ฒ๐ฟ๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป ๐ณ๐ฎ๐ฐ๐๐ผ๐ฟ๐ such as temperature, induction strategy, dissolved oxygen, pH, and feeding strategy ๐๐ต๐ฎ๐ฝ๐ฒ ๐ถ๐ป๐ฐ๐น๐๐๐ถ๐ผ๐ป ๐ฏ๐ผ๐ฑ๐ ๐พ๐๐ฎ๐น๐ถ๐๐, ๐๐ถ๐ฒ๐น๐ฑ, ๐ฎ๐ป๐ฑ ๐๐๐ฏ๐๐ฒ๐พ๐๐ฒ๐ป๐ ๐ฟ๐ฒ๐ณ๐ผ๐น๐ฑ๐ถ๐ป๐ด ๐๐๐ฐ๐ฐ๐ฒ๐๐.
๐ Download the white paper and learn how we implement a quality by design (QbD) approach to maximize inclusion body quality:
https://hubs.ly/Q04wKZjp0
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
21511 23rd Drive SE
Bothell, WA
98021
Opening Hours
| Monday | 8am - 5pm |
| Tuesday | 8am - 5pm |
| Wednesday | 8am - 5pm |
| Thursday | 8am - 5pm |
| Friday | 8am - 5pm |